Literature DB >> 4306640

The synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. I. Some properties of the enzyme from P1534J mouse leukemic cells.

P Reyes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4306640     DOI： 10.1021/bi00833a041

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  10 in total

1.  Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro.

Authors:  P K Rathod; A Khatri; T Hubbert; W K Milhous
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

2.  Uracil phosphoribosyl transferase activity of mycoplasma and infected cell cultures.

Authors:  C W Long; R DelGiudice; R S Gardella; M Hatanaka
Journal:  In Vitro       Date:  1977-07

3.  Characterisation of a partially purified uracil phosphoribosyltransferase from the opportunistic pathogen Candida albicans.

Authors:  H M Alloush; D Kerridge
Journal:  Mycopathologia       Date:  1994-03       Impact factor: 2.574

Review 4.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

5.  Properties of pea seedling uracil phosphoribosyltransferase and its distribution in other plants.

Authors:  R A Bressan; M G Murray; J M Gale; C W Ross
Journal:  Plant Physiol       Date:  1978-03       Impact factor: 8.340

6.  Regulation of orotidylic acid pyrophosphorylase in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1972-01       Impact factor: 3.490

7.  Incorporation of intermediary products of 5-FU anabolism into colorectal cancer.

Authors:  G R Giles; L Woodhouse; P J Finan; E M Chisholm
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

8.  Decreased host toxicity in vivo during chronic treatment with 5-flourouracil.

Authors:  J W Darnowski; R C Sawyer; R L Stolfi; D S Martin; C A Lau-Cam
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Comparative levels of tissue enzymes concerned in the early metabolism of 5-fluorouracil in normal and malignant human colorectal tissue.

Authors:  P J Finan; P A Koklitis; E M Chisholm; G R Giles
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

10.  5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.

Authors:  C Roobol; G B De Dobbeleer; J L Bernheim
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.